Table 1.

Factors for consideration when mining the EHR for patients at risk of CKD progression

Metformin use in patients with a diminished eGFR
Inadequate BP control
Progressive decline in eGFR from baseline
Acute decline in eGFR by predetermined parameters
Doubling in degree of proteinuria over a defined window
Initiation of ACE inhibitor or ARB and no follow-up BMP 1 mo after initiation
Recurrent hyperkalemia >6 mmol/L
Recurrent CHF admissions
Hemoglobin <9 g/dl and no referral to the anemia management program
eGFR < 25 ml/min per 1.73 m2 and no referral to the nephrology department
  • The target population includes patients with an eGFR ≤45 ml/min per 1.73 m2 or patients with proteinuria >500 mg/24 h. EHR, electronic health record; NSAID, nonsteroidal anti-inflammatory drug; eGFR, estimated GFR; ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; BMP, basic metabolic panel; CHF, congestive heart failure.